NEW COMPARISON: U.S. Drugs 2x to 9x Pricier than Canada

October 31, 2024 06:36 AM AEDT | By EIN Presswire
 NEW COMPARISON: U.S. Drugs 2x to 9x Pricier than Canada
Image source: EIN Presswire

WASHINGTON, DC, UNITED STATES, October 30, 2024 /EINPresswire.com/ -- One week from Election Day, the Campaign for Personal Prescription Importation (CPPI) has released a new price comparison between U.S. and Canadian pharmacies revealing that U.S. pharmacies just can’t compete with Canadian drug prices. CPPI compared prices of the most sought-after brand-name prescription drugs demonstrating that average Canadian drug prices are 50% to 90% less expensive than leading U.S. pharmacy prices.

The percentage of Americans who can afford and access prescription drugs and quality healthcare stands at a new low of 55%, a six-point decline since 2022, according to a September 2024, West Health-Gallup Healthcare Affordability Index. Meanwhile, the poll shows that the majority of Americans (67%) believe that healthcare is not receiving enough attention during the presidential campaign.

“Americans struggling with the life-and-death issue of prescription drug affordability are wanting solutions today, and that is where personal prescription importation comes in,” says CPPI Executive Director Jack Pfeiffer. “Millions of Americans, who’ve found themselves up against the wall, already turn to personal prescription importation to find prices 50-90% less expensive from safe licensed Canadian pharmacies. Millions more are looking to political leaders and candidates for solutions. It is time for Congress and the Administration to step up and pass legislation. The consequences of failing to act or denying Americans access to affordable medications are life and death.”

The Affordable and Safe Prescription Drug Importation Act (H.R. 8848 introduced by Rep. Jan Schakowsky), and the Safe and Affordable Drugs from Canada Act (S. 4918 introduced by Sen. Klobuchar and Sen. Grassley) would ensure and expand Americans’ access to affordable prescription drugs through importation. Both Kamala Harris and Donald Trump have proven their support for expanding prescription importation. Further, 78% of the public favors allowing Americans to buy prescription drugs imported from licensed Canadian pharmacies according to the Kaiser Family Foundation.

Canadian vs. U.S. Drug Price Savings

CPPI’s drug price comparison findings are consistent with U.S. Health and Human Services data showing that identical medications from Canada cost up to 90% less than the price charged in the United States, with the top 60 drugs sold in America costing nearly four times as much as Canada.

DRUGS ACT THREATENS ACCESS

Given rising inflation and increased living costs, CPPI advocates that “Americans need more access to affordable prescription medications, not less.” The organization recently pushed back against the introduction of the Domain Reform for Unlawful Drug Sellers Act (DRUGS Act) [S. 4108]. The bill introduced by Florida Senator Marco Rubio, would deny Americans access to safe and affordable daily prescription medicines from licensed international pharmacy websites.

“The DRUGS Act puts lives in jeopardy, and is the wrong direction for America,” says Pfeiffer.

HOW TO SAVE ON Rx SAFELY

Purchasing prescription medications for importation from licensed and certified online Canadian pharmacies is safe and easy. Annually, Americans receive over one million prescriptions from online Canadian pharmacies. For decades, FDA guidance has helped people safely import medications.

SAVINGS

2023 CPPI survey data shows that Americans importing prescription drugs save an average of $410 a month -$4,920 a year- on medication from licensed Canadian pharmacies. Ninety-five percent of respondents cited the high cost of prescription drugs in the U.S. as the primary reason for ordering from licensed online Canadian pharmacies. Ninety-three percent of respondents say that addressing the high cost of prescription drugs in the U.S. is important to how they will vote in the next election.

John Pfeiffer
CPPI
+1 202-641-8574
email us here
Visit us on social media:
Facebook
X
Instagram
Other

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.